The PPS may be down because average retail investors fear it may happen, and not necessarily because they think it will. The intelligent investors on this forum have nicely pinpointed Titan's current and potential future cash positions after the last raise...and as we all know they will have the requisite amount to get to FDA submission barring anymore major revisions that they feel need to be done to SPORT.
I'd like to see some google analytics data on how many people visit this site to only lurk, and not contribute, to the Titan Medical discussions. If there aren't many people reading this forum, then they may not know what we know and hence their investing strategy is misguided. In other words, it's a good time for us to load up.
Nothing I see indicates trouble. The last PR out of Columbia was a bit lackluster, but as Flenderson said it isn't Advincula's style to be boastful. Knowing several surgeons myself, I am inclined to believe that. The only potential problem I see is any final revisions to SPORT, but even then it seems they would be small and likely wouldn't affect the FDA timeline although it may add to the cost to get to FDA submission.
Anyway, that's my take on it. I am optimistic and wishing I had more cash on hand to have bought more this week. GLTA and thanks for the discussions.
Market Data 
Markets 
AI
